Showing results (21-30 of 35) with videos related to
Sort By:
Pageof 4
Arthritis and Rheumatism|May 20, 1998
Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1T Atsumi, M A Khamashta, R S Haworth, et al.Rheumatology (Oxford, England)|May 6, 2003
Cerebral imaging by magnetic resonance imaging and single photon emission computed tomography in systemic lupus erythematosus with central nervous system involvementK Oku, T Atsumi, S Furukawa, et al.Lupus|July 3, 2013
The involvement of CD36 in monocyte activation by antiphospholipid antibodiesM Kato, T Atsumi, K Oku, et al.Clinical and Experimental Rheumatology|August 19, 2000
Antiphospholipid antibodies in leprotic patients: a correlation with disease manifestationsA Elbeialy, K Strassburger-Lorna, T Atsumi, et al.Arthritis and Rheumatism|January 1, 2000
Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndromeF I Romero, T Atsumi, F J Tinahones, et al.Rheumatology (Oxford, England)|February 7, 2001
HLA class II gene polymorphisms in antiphospholipid syndrome: haplotype analysis in 83 Caucasoid patientsR Caliz, T Atsumi, E Kondeatis, et al.Lupus|June 30, 2017
Effects of statins on thrombosis development in patients with systemic lupus erythematosus and antiphospholipid antibodiesT Watanabe, K Oku, O Amengual, et al.Lupus|September 1, 2012
Predominant prevalence of arterial thrombosis in Japanese patients with antiphospholipid syndromeY Fujieda, T Atsumi, O Amengual, et al.The Journal of Rheumatology|November 18, 1998
Antibodies to beta2-glycoprotein I: a potential marker for clinical features of antiphospholipid antibody syndrome in patients with systemic lupus erythematosusS S Sanfilippo, M A Khamashta, T Atsumi, et al.Lupus|October 23, 2019
Factor Xa inhibitors for preventing recurrent thrombosis in patients with antiphospholipid syndrome: a longitudinal cohort studyT Sato, H Nakamura, Y Fujieda, et al.Pageof 4